Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,757.46
(
-1.55%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.15
(
7.45%
)
Bitcoin
71,090.59
(
-3.86%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tinkershaw post# 116320

Thursday, 03/10/2011 11:57:55 PM

Thursday, March 10, 2011 11:57:55 PM

Post# of 257253

…here is a [hypothetical] scenario no one else has broached: what if the FDA approves both m-copaxone and t-lovenox on the same day! I think MNTA share price skyrockets once the market actually takes into account what just happened with Copaxone…

Agreed—in your wildly unlikely scenario, MNTA’s share price would go up substantially, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today